Literature DB >> 1368874

Erythropoietin and myeloid colony stimulating factors.

G J Cowling1, T M Dexter.   

Abstract

The production of blood cells in the body is controlled by at least 20 polypeptide growth factors. Most of these factors have been cloned and many expressed in bacterial and eukaryotic systems to give biologically active proteins. Currently, these recombinant human proteins are undergoing intensive evaluation for their use in treating primary haemopoietic diseases, or stimulating normal haemopoiesis following drug-, radiation- or virus-induced trauma of the bone marrow. Erythropoietin (EPO) and the myeloid colony stimulating factors (IL-3, G-CSF, GM-CSF and M-CSF) were among the first to be cloned and expressed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1368874     DOI: 10.1016/0167-7799(92)90267-y

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  4 in total

Review 1.  Optimizing the effectiveness of hematopoietic growth factors.

Authors:  D E Williams
Journal:  J Clin Immunol       Date:  1994-07       Impact factor: 8.317

2.  Erythroid differentiation denucleation factors (EDDFs) function as intrinsic, post-erythropoietin regulators for mammalian erythroid terminal differentiation.

Authors:  S-P Xue; S-F Zhang; W Ma; Z Zhang; P Liu; Q Zhao; D Han
Journal:  Cell Prolif       Date:  2006-02       Impact factor: 6.831

3.  Large-scale sequencing of two regions in human chromosome 7q22: analysis of 650 kb of genomic sequence around the EPO and CUTL1 loci reveals 17 genes.

Authors:  G Glöckner; S Scherer; R Schattevoy; A Boright; J Weber; L C Tsui; A Rosenthal
Journal:  Genome Res       Date:  1998-10       Impact factor: 9.043

4.  Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice.

Authors:  J C Segovia; J M Gallego; J A Bueren; J M Almendral
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.